Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant
Clinical trial NCT03359746 · UNKNOWN
Trial details
- NCT number
- NCT03359746
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2018-10-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.